收费全文 | 4398篇 |
免费 | 412篇 |
国内免费 | 42篇 |
耳鼻咽喉 | 33篇 |
儿科学 | 127篇 |
妇产科学 | 91篇 |
基础医学 | 708篇 |
口腔科学 | 87篇 |
临床医学 | 480篇 |
内科学 | 788篇 |
皮肤病学 | 94篇 |
神经病学 | 292篇 |
特种医学 | 382篇 |
外科学 | 565篇 |
综合类 | 123篇 |
一般理论 | 3篇 |
预防医学 | 333篇 |
眼科学 | 133篇 |
药学 | 417篇 |
中国医学 | 3篇 |
肿瘤学 | 193篇 |
2021年 | 51篇 |
2020年 | 31篇 |
2019年 | 61篇 |
2018年 | 83篇 |
2017年 | 59篇 |
2016年 | 52篇 |
2015年 | 84篇 |
2014年 | 108篇 |
2013年 | 133篇 |
2012年 | 202篇 |
2011年 | 201篇 |
2010年 | 134篇 |
2009年 | 130篇 |
2008年 | 171篇 |
2007年 | 206篇 |
2006年 | 156篇 |
2005年 | 149篇 |
2004年 | 165篇 |
2003年 | 138篇 |
2002年 | 134篇 |
2001年 | 136篇 |
2000年 | 122篇 |
1999年 | 120篇 |
1998年 | 117篇 |
1997年 | 82篇 |
1996年 | 69篇 |
1995年 | 71篇 |
1994年 | 58篇 |
1993年 | 63篇 |
1992年 | 101篇 |
1991年 | 101篇 |
1990年 | 94篇 |
1989年 | 99篇 |
1988年 | 104篇 |
1987年 | 110篇 |
1986年 | 88篇 |
1985年 | 71篇 |
1984年 | 69篇 |
1983年 | 65篇 |
1982年 | 42篇 |
1981年 | 46篇 |
1980年 | 33篇 |
1979年 | 56篇 |
1978年 | 46篇 |
1977年 | 35篇 |
1975年 | 36篇 |
1973年 | 31篇 |
1972年 | 51篇 |
1971年 | 40篇 |
1969年 | 30篇 |
Objectives
To investigate whether functional overreaching affects locomotor system behaviour when running at fixed relative intensities and if any effects were associated with changes in running performance.Design
Prospective intervention study.Methods
Ten trained male runners completed three training blocks in a fixed order. Training consisted of one week of light training (baseline), two weeks of heavy training designed to induce functional overreaching, and ten days of light taper training designed to allow athletes to recover from, and adapt to, the heavy training. Locomotor behaviour, 5-km time trial performance, and subjective reports of training status (Daily Analysis of Life Demands for Athletes (DALDA) questionnaire) were assessed at the completion of each training block. Locomotor behaviour was assessed using detrended fluctuation analysis of stride intervals during running at speeds corresponding to 65% and 85% of maximum heart rate (HRmax) at baseline.Results
Time trial performance (effect size ±95% confidence interval (ES): 0.16 ± 0.06; p < 0.001), locomotor behaviour at 65% HRmax (ES: ?1.12 ± 0.95; p = 0.026), and DALDA (ES: 2.55 ± 0.80; p < 0.001) were all detrimentally affected by the heavy training. Time trial performance improved relative to baseline after the taper (ES: ?0.16 ± 0.10; p = 0.003) but locomotor behaviour at 65% HRmax (ES: ?1.18 ± 1.17; p = 0.048) and DALDA (ES: 0.92 ± 0.90; p = 0.045) remained impaired.Conclusions
Locomotor behaviour during running at 65% HRmax was impaired by functional overreaching and remained impaired after a 10-day taper, despite improved running performance. Locomotor changes may increase injury risk and should be considered within athlete monitoring programs independently of performance changes. 相似文献Methods: We performed a systematic review of all available publications and extracted data from national and international guidelines. The Task Force evaluated the data with respect to the strength of evidence for the efficacy and safety of each medication.
Results and Discussion: There is no safe level of alcohol use during pregnancy. Abstinence is recommended. Ideally, women should stop alcohol use when pregnancy is planned and, in any case, as soon as pregnancy is known. Detecting patterns of alcohol maternal drinking should be systematically conducted at first antenatal visit and throughout pregnancy. Brief interventions are recommended in the case of low or moderate risk of alcohol use. Low doses of benzodiazepines, for the shortest duration, may be used to prevent alcohol withdrawal symptoms when high and chronic alcohol intake is stopped and hospitalisation is recommended. Due to the low level of evidence and/or to low benefit/risk ratio, pharmacological treatment for maintenance of abstinence should not be used during pregnancy. At birth, foetal alcohol spectrum disorders must be searched for, and alcohol metabolites should be measured in meconium of neonates in any doubt of foetal alcohol exposure. 相似文献